These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8255773)

  • 1. Design and specificity of hammerhead ribozymes against calretinin mRNA.
    Ellis J; Rogers J
    Nucleic Acids Res; 1993 Nov; 21(22):5171-8. PubMed ID: 8255773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects.
    Grassi G; Forlino A; Marini JC
    Nucleic Acids Res; 1997 Sep; 25(17):3451-8. PubMed ID: 9254703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability.
    Hendry P; McCall MJ; Santiago FS; Jennings PA
    Nucleic Acids Res; 1992 Nov; 20(21):5737-41. PubMed ID: 1280808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural analysis of in vitro catalytic activities of hammerhead ribozymes.
    Shao Y; Wu S; Chan CY; Klapper JR; Schneider E; Ding Y
    BMC Bioinformatics; 2007 Nov; 8():469. PubMed ID: 18053134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clone, expression and cleavage activity of anti-caspase-7 hammerhead ribozyme in vitro].
    Zhang W; Xie Q; Zhou XQ; Jiang S; Jin YX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):684-7. PubMed ID: 15623380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cleavage of a hammerhead ribozyme targeted to beta-amyloid peptide precursor mRNA.
    Denman R; Miller DL
    Arch Biochem Biophys; 1993 Sep; 305(2):392-400. PubMed ID: 8373177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and characterization of ribozyme for tissue inhibitor of metalloproteinases-1 mRNA ribozymes in vitro].
    Wang ZM; Wu JM; Lin ZH; Jiang H; Song YH; Jin YX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):387-90. PubMed ID: 12673396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex formation determines the activity of ribozymes directed against potato virus YN genomic RNA sequences.
    van der Vlugt RA; Prins M; Goldbach R
    Virus Res; 1993 Feb; 27(2):185-200. PubMed ID: 8460529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
    Hovig E; Maelandsmo G; Mellingsaeter T; Fodstad O; Mielewczyk SS; Wolfe J; Goodchild J
    Antisense Nucleic Acid Drug Dev; 2001 Apr; 11(2):67-75. PubMed ID: 11334142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of hammerhead ribozymes for optimum cleavage of interleukin 6 mRNA.
    Hendrix C; Anné J; Joris B; Van Aerschot A; Herdewijn P
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):655-61. PubMed ID: 8670082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of hammerhead ribozyme kinetic constants at high molar ratio ribozyme-substrate.
    Grassi G; Grassi M; Kuhn A; Kandolf R
    J Math Biol; 2002 Sep; 45(3):261-77. PubMed ID: 12373347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can hammerhead ribozymes be efficient tools to inactivate gene function?
    Bertrand E; Pictet R; Grange T
    Nucleic Acids Res; 1994 Feb; 22(3):293-300. PubMed ID: 7510389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1.
    Bertrand EL; Rossi JJ
    EMBO J; 1994 Jun; 13(12):2904-12. PubMed ID: 8026475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase.
    Sioud M; Jespersen L
    J Mol Biol; 1996 Apr; 257(4):775-89. PubMed ID: 8636981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.